By Dr. Asnat Raziel, bariatric surgeon specializing in obesity treatment, metabolic health and healthy longevity; Director of the Multidisciplinary Center for Obesity Treatment, Assia Medical, Assuta Ramat HaChayal, Tel Aviv
Inflammaging: what long-lived families can teach us
The link between genes and longevity, and especially the role of inflammaging, has intrigued researchers for decades. In some families, good health seems to be inherited. The grandparents reach a very old age while staying active and independent. Their children pass 70 without diabetes or heart disease, and the next generation also gets sick later than average. Is this only a matter of shared habits, social conditions and luck? Or is there also a biological protection that is passed down?
A new study from the Netherlands offers an intriguing answer. The researchers identified several rare genetic changes in families in which several generations reached old age in good health. One of them is in the CGAS gene, which regulates the immune system and inflammation. The change weakens an inflammatory mechanism that grows stronger with age, without disabling the body’s ability to fight infections.
In this article, I focus on this side of the study: what inflammaging is, how it is linked to the cell’s internal alarm, and why turning it down in a controlled way may protect us. A broad review of the family study and the genes it found appears in my article on why some families age more slowly.
Not just how many years, but how we live them
Life expectancy has risen sharply in recent decades. However, healthy years have not risen at the same pace. An analysis of data from 183 countries showed an average gap of 9.6 years between life expectancy and health expectancy. In other words, many people live long years with diabetes, heart disease, cognitive decline and limitations.
That is why modern research focuses on healthspan. This is the number of years a person lives without significant chronic disease or cognitive decline, while staying independent. I also wrote about this approach in my article on healthspan and longevity.
Thirteen more years of health?
The Dutch group is the Leiden Longevity Study. Earlier studies in this group found a surprising figure. Members of the middle generation, born to long-lived parents, developed cardiometabolic diseases about 13 years later than their spouses. The spouses came from families with ordinary life expectancy.
This comparison is especially interesting. Spouses usually share a home, a diet and a similar environment. However, they do not share the same genetic makeup. To be precise, this is not a promise that everyone from such a family will get 13 extra years of health. The figure only shows that a tendency to age in good health may be inherited. That is exactly why the researchers looked for the link between genes and longevity within the families themselves.
How they searched for genes within whole families
Instead of testing individuals, the researchers studied 212 groups of brothers and sisters. All of them came from families with an unusual concentration of long lives. The family-based approach makes it possible to find rare changes that broad studies in the general population might miss.
First, the researchers located four regions on the chromosomes where the chance of finding longevity factors was high. In this way, they narrowed the search from about 20,000 genes to only about 350. Next, a further analysis revealed 12 rare variants that change the structure of a protein, in seven genes: NUP210L, SLC27A3, CD1A, CGAS, IBTK, RARS2 and SH2D3A. The standout finding was a single-letter change in the CGAS gene called rs200818241, which appeared in two families.
I want to stress that this change is very rare. It appeared in only a small number of families, so we should not see it as the one “longevity gene.”
Inflammaging and the cell’s alarm system
The CGAS gene, short for cyclic GMP-AMP synthase, makes a protein that acts as an alarm sensor inside the cell. Normally, our genetic material sits in the cell nucleus and in the mitochondria. When DNA shows up in the cytoplasm, where it should not be, the protein detects it.
This happens during a viral infection, but also when cells are damaged and DNA leaks into the wrong place. The sensor then switches on a pathway called cGAS-STING. The pathway triggers an immune response, the production of interferons and the release of inflammatory substances. It is a vital mechanism for protection against infections.
However, with age, DNA damage, mitochondrial injury and old cells build up. As a result, the alarm may keep sounding even without an infection. Long-term activation contributes to inflammaging, a chronic low-grade inflammation that accompanies aging. A study published in Nature showed that blocking STING in mice reduced age-related inflammation in several organs and in the brain. I have written at length about the link between chronic inflammation and metabolic health.
Inflammaging: turn down the alarm, don’t switch it off
The change found in the families does not switch the protein off. In experiments in human and mouse cells, it reduced the protein’s stability. In addition, it weakened activation of the pathway. The effect depended on the cell type, but overall the inflammatory signaling went down. Moreover, the cells showed fewer signs of cellular aging.
Perhaps members of these families were born with an immune system that responds to threats, but does not respond strongly and for a long time to every small injury. This is a delicate balance. Shutting the sensor down completely could impair the detection of infections, and perhaps of cancer cells too. On the other hand, chronic overactivity damages tissues. So the message is not to “block inflammation” across the board, but to keep the response precise.

Inflammaging at a glance
How do all the pieces fit together? First, with age, DNA damage, mitochondrial injury and old cells build up. Second, DNA that leaks into the cytoplasm switches on the cGAS-STING pathway, even without an infection. As a result, chronic low-grade inflammation develops and damages tissues. By contrast, the rare change found in long-lived families weakens the pathway without disabling it. In mice, blocking STING reduced age-related inflammation in several organs and in the brain. So the future goal is not to switch off the immune system, but to keep its response precise.
Could the discovery lead to a drug against inflammaging?
The study marks the cGAS-STING pathway as a possible target for future drugs against age-related inflammation. In theory, a treatment that moderates the pathway without disabling it would mimic part of the effect of the genetic change. You can read about this direction and about other compounds in my article on drugs that target aging.
Still, the road to treatment in humans is long. A finding in cells does not prove that the variant extends life. In addition, the change appeared in only two families. The researchers released the work as a preprint and presented it in June 2026 at the European Society of Human Genetics conference. So it still needs peer review and replication.
The next stage will take place at the Max Planck Institute for Biology of Ageing in Cologne. There, researchers will introduce the change into killifish, which naturally live only three to nine months. This way, they will be able to test quickly whether the change affects the lifespan of a whole organism.
Genes and longevity: genes are not destiny
The study does not reduce the importance of lifestyle. Movement, nutrition, sleep, not smoking and social ties strongly affect healthspan. Even in long-lived families, some people get sick early. Conversely, in ordinary families, some people reach a very old age in good health.
The link between genes and longevity is complex. Longevity arises from a combination of thousands of genetic differences, repair mechanisms, the immune system, metabolism and environment. The accepted model of the hallmarks of aging lists 12 mechanisms, and chronic inflammation is only one of them. That is why small changes in lifestyle can also make a difference.
The bottom line
The value of this study is not a blood test that will reveal who is “meant” to live to 100. Its value is in showing which natural mechanisms protect certain people. Once science understands how these families keep the balance between immune protection and inflammation, we can look for ways to mimic it. Meanwhile, if you want to know how the pace of aging is actually measured, you can read about epigenetic clocks.
Perhaps the secret of longevity is not in switching on a new mechanism. Perhaps it lies in the ability to stop a protective mechanism from working too hard and for too long. Health in old age depends not only on the ability to fight, but also on knowing when to stop.
The information in this article is general and does not replace personal medical advice.
References
New research helps understand how a long, healthy lifespan may be passed down across generations
Family genetics study reveals clues to longer healthspan
cGAS-STING drives ageing-related inflammation and neurodegeneration
Global Healthspan-Lifespan Gaps Among 183 World Health Organization Member States



